Follow
Nicholas Mitsiades
Nicholas Mitsiades
Chief Translational Officer, Comprehensive Cancer Center, UC Davis Health
Verified email at ucdavis.edu
Title
Cited by
Cited by
Year
Integrative genomic profiling of human prostate cancer
BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ...
Cancer cell 18 (1), 11-22, 2010
40572010
NF-κB as a therapeutic target in multiple myeloma
T Hideshima, D Chauhan, P Richardson, C Mitsiades, N Mitsiades, ...
Journal of Biological Chemistry 277 (19), 16639-16647, 2002
11802002
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
N Mitsiades, CS Mitsiades, PG Richardson, V Poulaki, YT Tai, D Chauhan, ...
Blood, The Journal of the American Society of Hematology 101 (6), 2377-2380, 2003
9352003
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
N Mitsiades, CS Mitsiades, V Poulaki, D Chauhan, G Fanourakis, X Gu, ...
Proceedings of the National Academy of Sciences 99 (22), 14374-14379, 2002
9332002
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
D Chauhan, L Catley, G Li, K Podar, T Hideshima, M Velankar, ...
Cancer cell 8 (5), 407-419, 2005
8442005
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
N Mitsiades, CS Mitsiades, V Poulaki, D Chauhan, PG Richardson, ...
Blood, The Journal of the American Society of Hematology 99 (12), 4525-4530, 2002
8322002
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
CS Mitsiades, NS Mitsiades, CJ McMullan, V Poulaki, R Shringarpure, ...
Cancer cell 5 (3), 221-230, 2004
7932004
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
A M. Joussen, V Poulaki, N Mitsiades, B Kirchhof, K Koizumi, S Döhmen, ...
The FASEB journal 16 (3), 438-440, 2002
7662002
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
T Hideshima, C Mitsiades, M Akiyama, T Hayashi, D Chauhan, ...
Blood, The Journal of the American Society of Hematology 101 (4), 1530-1534, 2003
7522003
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications
CS Mitsiades, NS Mitsiades, CJ McMullan, V Poulaki, R Shringarpure, ...
Proceedings of the National Academy of Sciences 101 (2), 540-545, 2004
6752004
Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model
R LeBlanc, LP Catley, T Hideshima, S Lentzsch, CS Mitsiades, ...
Cancer research 62 (17), 4996-5000, 2002
6342002
Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications
CS Mitsiades, N Mitsiades, V Poulaki, R Schlossman, M Akiyama, ...
Oncogene 21 (37), 5673-5683, 2002
6262002
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity
N Mitsiades, W Yu, V Poulaki, M Tsokos, I Stamenkovic
Cancer research 61 (2), 577-581, 2001
5412001
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
CS Mitsiades, SP Treon, N Mitsiades, Y Shima, P Richardson, ...
Blood, The Journal of the American Society of Hematology 98 (3), 795-804, 2001
5052001
Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications
N Mitsiades, CS Mitsiades, V Poulaki, D Chauhan, PG Richardson, ...
Blood, The Journal of the American Society of Hematology 99 (11), 4079-4086, 2002
5042002
Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal …
AM Joussen, V Poulaki, W Qin, B Kirchhof, N Mitsiades, SJ Wiegand, ...
The American journal of pathology 160 (2), 501-509, 2002
4942002
Antimyeloma activity of heat shock protein-90 inhibition
CS Mitsiades, NS Mitsiades, CJ McMullan, V Poulaki, AL Kung, FE Davies, ...
Blood 107 (3), 1092-1100, 2006
4022006
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
DW McMillin, J Delmore, E Weisberg, JM Negri, DC Geer, S Klippel, ...
Nature medicine 16 (4), 483-489, 2010
3772010
Molecular sequelae of histone deacetylase inhibition in human malignant B cells
N Mitsiades, CS Mitsiades, PG Richardson, C McMullan, V Poulaki, ...
Blood, The Journal of the American Society of Hematology 101 (10), 4055-4062, 2003
3692003
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway
R LeBlanc, T Hideshima, LP Catley, R Shringarpure, R Burger, ...
Blood 103 (5), 1787-1790, 2004
3512004
The system can't perform the operation now. Try again later.
Articles 1–20